0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Solid Tumor"

From
EUR$3,825USDGBP
EUR$4,500USDGBP
Prostate Cancer - Competitive landscape, 2024 - Product Thumbnail Image

Prostate Cancer - Competitive landscape, 2024

  • Clinical Trials
  • November 2024
  • 450 Pages
  • Global
From
EUR$5,000USDGBP
From
EUR$3,750USDGBP
From
EUR$4,949USDGBP
2022 ASCO Weekend Update - Product Thumbnail Image

2022 ASCO Weekend Update

  • Newsletter
  • June 2025
  • 88 Pages
  • Global
EUR$1,318USDGBP
From
EUR$2,625USDGBP
EUR$5,250USDGBP
From
EUR$2,625USDGBP
EUR$5,250USDGBP
Innovation Waves in Immuno-oncology Therapy Development - Product Thumbnail Image

Innovation Waves in Immuno-oncology Therapy Development

  • Report
  • February 2024
  • 75 Pages
  • Global
From
EUR$4,950USDGBP
From
EUR$3,825USDGBP
EUR$4,500USDGBP
From
EUR$4,949USDGBP
From
EUR$7,950USDGBP
From
EUR$9,500USDGBP
From
EUR$7,500USDGBP
From
EUR$3,825USDGBP
EUR$4,500USDGBP
From
EUR$4,750USDGBP
Loading Indicator

The Solid Tumor market within the context of Oncology is a highly competitive and rapidly evolving field. It is focused on the development of treatments for solid tumors, which are malignant tumors that form in the body's organs and tissues. These tumors can be caused by a variety of factors, including genetic mutations, environmental exposures, and lifestyle choices. Treatment options for solid tumors include surgery, chemotherapy, radiation therapy, and targeted therapies. The Solid Tumor market is driven by the increasing prevalence of cancer, advances in technology, and the development of new treatments. Companies in this market are focused on developing innovative treatments and therapies to improve patient outcomes. Examples of companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more